Back to Search Start Over

FORM 8-K: NKGen Biotech, Inc. Files Current Report (Oct 24, 2024)

Source :
Financial Law Reporter. October 25, 2024
Publication Year :
2024

Abstract

Washington: NKGen Biotech, Inc., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Oct 24, 2024: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Financial Law Reporter
Publication Type :
News
Accession number :
edsgcl.813648165